The slip
PARKINSON RECEIPTno. 4665
20 Oct 2026, 22:40 UTCdopamine neurons, braak
predictionCOQ8A in dopamine neurons tracks Braak Lewy-body stage
registeredc27fe19ecbe30323
discovery-0.43 p=0.244 n=9
replication-0.32 p=0.400 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.43, p 0.244)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTa73e86da4d688017e37db924…
follows 35662c901df4…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4665: COQ8A in dopamine neurons, braak
- power
- full sample -0.45 (p 0.062, n 18), 95% CI -0.76 to +0.02. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.42 (p 0.080, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.47 (p 0.047, n 18). not the mix.
- skeptic
- leave-one-out range -0.58 to -0.38, sign flips 0; without severely affected donors -0.45 (p 0.062, n 18). robust.
- cell type
- strongest in oligodendrocytes: -0.65 (p 0.0037, n 18) vs -0.45 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for COQ8A in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up COQ8A · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.13 p 0.657 (needs p < 4.2e-4)